Table 1 Some of targeted therapies in control and treatment of asthma

From: Targeting cell signaling in allergic asthma

 

Target

Effects

Th2high/low

References

Cell surface protein

Siglec-8

Apoptosis of eosinophils

High

294, 295

CD300a

Activation of inhibitory receptor

High

296

α4β1, α4β7

Increase blood eosinophils and inhibits their tissue accumulation

High

297

CCR3

Block chemokine-induced eosinophils

High

298

CXCR2

Reduce neutrophils

Low

16

CD52

Deplete eosinophils

High

299

EMR1

Deplete primate eosinophils

High

300

CRTH2

Reduce tissue eosinophils

High

301

Transcription factor

GATA3

Reduce IL-5

High

302

Soluble mediator antagonist

Eotaxin-1

Inhibit eosinophil migration

High

303, 304

IgE

Reduces allergic inflammation and exacerbations and airway obstruction

High

305, 306

IL-4

Reduce allergic inflammation

High

307, 308

IL-13

Reduce airway obstruction and cough

High

309, 310

Interleukin-17RA

Reduce Th17 response

Low

311

TSLP

Reduce eosinophils and allergic inflammation

High

312

PGD2

improved Lung function

High

313, 314